| Budget Amount *help |
¥24,180,000 (Direct Cost: ¥18,600,000、Indirect Cost: ¥5,580,000)
Fiscal Year 2020: ¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2019: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥7,280,000 (Direct Cost: ¥5,600,000、Indirect Cost: ¥1,680,000)
Fiscal Year 2017: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
|
|---|
| Outline of Final Research Achievements |
The primary aim of this study was to test the efficacy of a unified protocol of transdiagnostic treatment for depressive and anxiety disorders (UP) by a randomized controlled trial. Other objectives were to examine the therapeutic mechanism, neural basis, and long-term effects of UP. The clinical trial achieved the enrollment of the target number of 104 patients. The data was fixed, statistically analyzed. Drafting the primary outcome paper has almost completed. In addition, we obtained the participants' brain image at before and after the intervention. Using the data from preliminary trial and observational studies, we published articles on the therapeutic mechanisms and processes of UP. Interventional materials and other materials prepared for clinical trials have been used extensively for education and training of UP.
|
